---
title: "TRT: The Testosterone Replacement Therapy Guide"
description: "What TRT is, indications, physiological-dose protocols, lifelong monitoring — a complete patient-side guide."
lang: en
dateModified: 2026-05-23
canonical: https://anaprotokol.com/en/guides/trt-protocol-guide
---

# TRT: The Testosterone Replacement Therapy Guide

**TRT (testosterone replacement therapy)** is a medical treatment for hypogonadism: a controlled dose of exogenous testosterone meant to bring a serum level that is too low back into a physiological range. It is not a cycle, it is not a stack, and it is not a performance protocol. It is a long-term medical intervention — typically lifelong — under prescription, with a clinical-health objective and a recurring lab schedule.

This guide is the head of the AnaProtoKol TRT cluster. It covers the basics: what TRT actually is medically, who really qualifies, which esters and which injection frequencies are used in modern clinics, how [HCG](/en/molecule/hcg) preserves fertility, when an aromatase inhibitor is appropriate (and when it isn't), and the lifelong monitoring the treatment implies. For the symptoms that should prompt a workup, see the [low testosterone symptoms](/en/guides/low-testosterone-symptoms) guide; for the line between medical TRT and a performance cycle, see [TRT vs steroid cycle](/en/guides/trt-vs-steroid-cycle).

## What TRT is and what it is for

TRT supplies exogenous testosterone to replace — or compensate for — a failing endogenous production. Medically, it is the standard treatment for confirmed **male hypogonadism**: a biologically low testosterone level combined with clinical symptoms. The goal is not to push to the top of the range, and not to add muscle — it is to restore a hormonal balance compatible with health, libido, body composition, mood and energy. US TRT clinics (Defy Medical, Marek Health, Hone Health, Maximus) and compounding pharmacies (Empower Pharmacy) work from the same framework, even when their delivery models differ.

Two broad categories of hypogonadism are treated with TRT. **Primary hypogonadism** is a direct testicular problem — genetic conditions (Klinefelter), trauma, post-infectious damage, chemotherapy — where LH and FSH are elevated but the testes do not respond. **Secondary hypogonadism** sits upstream, at the hypothalamic-pituitary level — pituitary tumors, head trauma, certain medications — where LH and FSH are low or inappropriate. A full hormonal workup (total T, free T, SHBG, LH, FSH, prolactin) draws the distinction, as detailed in [interpreting hormonal markers](/en/guides/hormonal-markers-on-cycle).

> TRT is a lifelong medical treatment in most cases: once started, the HPTA stays suppressed and endogenous production rarely restarts spontaneously on discontinuation. The decision belongs with an endocrinologist or a urologist trained in hypogonadism, on the basis of solid lab evidence — not on a single subjective complaint or one online symptom quiz.

## Who actually qualifies for TRT

A hypogonadism diagnosis rests on two pieces fitting together: a **confirmed low total testosterone** (ideally two morning fasting draws at least a week apart) AND **compatible clinical symptoms**. One without the other is not enough. An isolated low number in an asymptomatic man warrants follow-up, not necessarily treatment. Symptoms without a low number point somewhere else — sleep, depression, deconditioning, medication side effects [1].

### Reference ranges in practice

- **Physiological range for total testosterone in adult men: roughly 300 to 1000 ng/dL** (10 to 35 nmol/L). Exact cut-offs vary by lab and by guideline body (AUA, Endocrine Society).
- **Common low threshold: < 300 ng/dL** (about < 10 nmol/L) on two morning draws — the level at which TRT starts to get seriously considered if symptoms are present [1] [2].
- Free T and SHBG round out the picture: a total in range with a low free T (very high SHBG) can still justify treatment.
- LH and FSH tell you the cause: elevated → primary; low or inappropriate → secondary.

### Main indications

- Confirmed primary hypogonadism (Klinefelter, anorchia, post-chemo damage).
- Confirmed secondary hypogonadism of hypothalamic-pituitary origin.
- Persistent post-cycle hypogonadism after several failed PCT attempts — see the [PCT protocol](/en/guides/pct-protocol-guide) guide.
- Late-onset hypogonadism in older men, with symptoms and biochemical confirmation — a more debated indication, evaluated case by case.

> TRT does not fix fatigue from poor sleep, weight from years of overeating, primary depression or simple deconditioning. Before starting, the workup should explore secondary causes of low T: excess body fat (adiposity mechanically lowers T), sleep apnea, chronic stress, vitamin D or zinc deficiency, opioid use. A meaningful share of 'low' readings climb back into range with lifestyle correction alone.

## Esters and injection frequency: the protocol baseline

Modern injectable TRT relies almost exclusively on a long testosterone ester: [testosterone cypionate (test cyp)](/en/molecule/test-cypionate) in US TRT practice, [testosterone enanthate](/en/molecule/test-enanthate) in UK and EU practice. The two are functionally interchangeable for TRT — enanthate (half-life ~4.5 days) and cypionate (~5 days) both give a stable kinetic profile, without aggressive peaks or deep troughs between doses.

### Dose and frequency

| Variable | Typical TRT range | Notes |
| --- | --- | --- |
| Weekly dose | 100 to 200 mg/week | Physiological replacement: upper half of normal range, not above |
| Frequency — classic schedule | 1 injection / week | Enough for low doses (100 to 140 mg) in most patients |
| Frequency — split schedule | 2 injections / week (E3.5D) | Better stability; recommended above 150 mg/week |
| Frequency — ultra-stable | EOD (every other day) | For patients sensitive to mood/estradiol swings |
| Route | IM or subQ | subQ TRT at physiological doses is well validated — see modern TRT clinic protocols |

To map ester decay between injections and dial in frequency, the [half-life calculator](/en/calculators/half-life) is a useful reference. Rule of thumb: if your trough readings (drawn just before the next injection) show a steep drop in T or estradiol, split the dose more often. The subQ vs IM TRT debate is largely settled in favor of either at physiological doses — patient preference and skin reaction drive the choice.

### Alternatives to injection

- **Transdermal gels (AndroGel, Testim, Fortesta)**: daily application, smoother serum levels but higher cost, risk of skin transfer to a child or partner, and variable absorption.
- **Patches (Androderm)**: less common in US TRT clinics today, frequent skin irritation.
- **Subcutaneous pellets (Testopel)**: inserted every 3 to 6 months, no daily routine, but dose is locked in for the period and removal is invasive.
- **Oral testosterone undecanoate (Jatenzo, Kyzatrex)**: FDA-approved, twice-daily dosing, expensive, must be taken with food.
- **Nasal gel (Natesto)**: interesting fertility profile (preserves LH/FSH better than other delivery modes), but three-times-daily application is a major adherence hurdle.

## HCG and fertility preservation on TRT

Exogenous testosterone on TRT shuts down LH and FSH secretion — this is mechanical and visible on any post-start bloodwork. FSH drives spermatogenesis, so its loss collapses sperm production in the vast majority of men. For a young patient, or anyone who is not done with family planning, this is a major point to address before the first injection, not after.

Adding [HCG](/en/molecule/hcg) alongside the testosterone (typically **250 to 500 IU two to three times per week**) mimics LH and keeps the testes active, including spermatogenesis [7]. Most men maintain normal testicular volume, retain enough sperm production for functional fertility, and report a better subjective feel on the protocol. For the protocols in detail and alternatives, see [TRT and fertility](/en/guides/trt-and-fertility) and [HCG on cycle and PCT](/en/guides/hcg-on-cycle-and-pct).

> An alternative to classic TRT for patients who absolutely want to preserve fertility: monotherapy with [clomiphene](/en/molecule/clomid) (or enclomiphene where available — Maximus and some US TRT clinics build entire protocols on it). It blocks central estrogen feedback and pushes endogenous LH/FSH back up, preserving both testosterone production and spermatogenesis. The serum level is less smooth than with injection-based TRT, but it keeps everything endogenous. A case-by-case discussion with the prescribing physician.

## Estradiol and aromatase inhibitors: restraint is the rule

Part of the testosterone aromatizes to estradiol — that is physiological and necessary. At TRT doses (100 to 200 mg/week), estradiol rises modestly and usually stays in or just above the normal male range. Estradiol contributes to libido, bone health, cognition and overall well-being: a crashed estradiol in a man is just as harmful as one that runs too high.

The classic 'gray TRT' (self-administered) mistake is to prescribe an [aromatase inhibitor](/en/molecule/anastrozole) systematically 'for safety'. In supervised practice, an AI gets introduced only with a **measured out-of-range estradiol AND associated clinical signs** (early gyno, marked water retention, estrogen-driven irritability). On a sensitive (E2 sensitive) assay — the only valid measure in men — many TRT patients never need an AI. When one is introduced, it is at the minimum dose and titrated against lab values. See [aromatase inhibitors on cycle](/en/guides/aromatase-inhibitors-on-cycle) for the deep dive.

> Crashing estradiol on TRT — usually from too much AI — causes joint pain, low libido, fatigue, low mood and long-term bone fragility. A lot of 'TRT does not work for me' stories are actually estradiol that runs too low, not too high. Rule: always measure E2 (sensitive assay) before adding an AI, and titrate slowly.

## Lifelong monitoring: labs, markers, adjustments

TRT is not a 'set and forget' prescription. It demands a recurring lab schedule for life — to titrate the dose, watch for side effects, and catch complications early. The AnaProtoKol blood-work feature lets you archive, date and trend these markers across years, which is exactly what your endocrinologist needs at the next visit.

### Typical TRT monitoring schedule

| Timing | Essential markers | Goal |
| --- | --- | --- |
| Before starting | Total T, free T, SHBG, LH, FSH, E2 sensitive, prolactin, CBC, PSA, lipid panel, CMP | Complete baseline, diagnosis, contraindications |
| 6 weeks after start | Total T (at trough), E2 sensitive, hematocrit | Confirm dose, adjust frequency if needed |
| 3 months | Total T, E2, hematocrit, CBC | Confirm steady state |
| 6 months then 1×/year | Full panel (hormones + CBC + lipids + PSA after 40) | Routine lifelong follow-up |
| Any new symptom | Targeted marker | Act before things drift |

### Key markers to watch

- **Hematocrit**: TRT increases red blood cell production. Above 52 to 54%, thrombotic risk climbs. Management: blood donation, dose reduction, more frequent splitting. See [hematocrit and steroids](/en/guides/hematocrit-and-steroids).
- **PSA and prostate**: TRT does not cause prostate cancer, but it can reveal a pre-existing one or accelerate benign hyperplasia. Annual surveillance after 40, tighter with family history [5].
- **Lipid panel**: HDL can drift. Trend it. See [cholesterol on cycle](/en/guides/cholesterol-on-cycle).
- **Blood pressure**: sodium retention can push BP up. Home cuff, regular readings [3]. See [heart health on cycle](/en/guides/heart-health-on-cycle).
- **Sleep apnea**: TRT can unmask or worsen apnea. Loud snoring, daytime fatigue or morning headaches warrant a sleep study.

For the broader monitoring framework, see the pillar [blood work on cycle](/en/guides/blood-work-on-cycle) and the timing in [blood test schedule on cycle](/en/guides/blood-test-schedule-cycle).

## Medical TRT vs gray TRT: the difference is real

A portion of TRT users self-administer without a formal diagnosis — usually after a cycle whose HPTA never recovered, or from empirical convenience. This 'gray TRT' is not equivalent to physician-supervised TRT. The differences are structural, not cosmetic. US forums (r/Testosterone, r/TRT, r/Hone, Excelmale, MESO-Rx TRT section) document both worlds, and the failure modes of the gray version are repeated week after week.

| Aspect | Medical TRT | Self-administered TRT |
| --- | --- | --- |
| Initial workup | Full panel, two morning draws, secondary causes ruled out | Often missing or based on symptom feel |
| Dose | Calibrated to physiological range, adjusted with labs | Variable, sometimes close to cruise/cycle doses |
| Follow-up | Scheduled, adjustments documented | Inconsistent |
| HCG for fertility | Offered as standard in young men | Often skipped |
| Estradiol | Sensitive assay measured before any AI | AI often prescribed 'for safety' |
| Source | Pharmacy or compounding pharmacy, verified product | Underground market, dose not guaranteed |
| Exit strategy | Documented medical decision | Often improvised and difficult |

> AnaProtoKol does not encourage self-administered TRT. If a hormone deficit is suspected, consulting an endocrinologist or a urologist trained in hypogonadism is the path that maximizes safety and quality of monitoring. The point of this guide is to inform factually, not to replace a medical consult.

## Expected effects, side effects, risks

### Expected effects at physiological dose

- Improved libido and erectile function (often noticeable within 4 to 8 weeks) [4].
- Gradual return of energy, motivation, sometimes mood [4].
- Modest but real recovery of strength and lean mass — without transforming the physique [4].
- Better bone mineral density over the long term [5].
- Gradual decline in abdominal fat.

### Possible side effects

- **Erythrocytosis (high hematocrit)**: the most common long-term effect [6]. Manage with blood donation, lower dose, or more frequent splitting. See [hematocrit and steroids](/en/guides/hematocrit-and-steroids).
- **Acne, oily skin, accelerated androgenic hair loss** in predisposed individuals. See [hair loss on steroids](/en/guides/hair-loss-on-steroids).
- **Suppression of spermatogenesis** — manageable with HCG alongside if fertility matters.
- **Testicular atrophy** — reduced with HCG; without HCG, testicular volume drops progressively.
- **Moderate fluid retention**, usually early in the protocol and transient.
- **Mood swings**, possible irritability when estradiol is mis-tuned.

### Major contraindications

- Active prostate or breast cancer.
- Uncorrected high hematocrit at baseline.
- Severe uncompensated heart failure.
- Severe untreated sleep apnea.
- Immediate fatherhood plans without HCG co-administration or a clomiphene-style alternative.

For the full picture of androgen side effects (relevant for TRT and cycles at very different intensities), see the pillar [steroid side effects guide](/en/guides/steroid-side-effects-guide).

## Coming off TRT: possible but slow

A long-running TRT has a durably suppressed HPTA. That does not mean stopping is impossible, but it is rarely easy and always slow. Three main scenarios:

- **Recent TRT (< 1 year) in a young man**: a medically supervised restart protocol (HCG plus a SERM, sometimes recombinant gonadotropins) can reignite the axis. Higher success rate, but no guarantee.
- **Long-term TRT**: restart is more uncertain. A fraction of patients recover acceptable endogenous production; others stay dependent on some form of treatment for life.
- **Primary hypogonadism (genetic or anatomical)**: there is no recovery to expect — the treatment is and will remain lifelong.

In every case, stopping or attempting to stop is done under medical supervision, never abruptly. Coming off TRT to switch to a performance cycle is a poorly conceived plan documented many times over — see [TRT vs steroid cycle](/en/guides/trt-vs-steroid-cycle).

## FAQ

### At what testosterone level is TRT indicated?

The common threshold is **below 300 ng/dL (about 10 nmol/L)** confirmed on two morning fasting draws at least a week apart, AND associated with compatible clinical symptoms (low libido, fatigue, erectile issues, loss of lean mass, low mood). An isolated low number without symptoms does not automatically warrant treatment; symptoms without a low number point to a different workup. The decision is medical and uses the full panel — see [low testosterone symptoms](/en/guides/low-testosterone-symptoms).

### Injection or gel — which should I pick?

Both work, and the choice depends on the patient. Injectable TRT (cypionate or enanthate, once or twice a week) gives more stable long-term levels, lower cost and usually better adherence. Transdermal gel is simpler to start (no needle), but requires daily application, exposes others (child, partner) to skin transfer risk, and absorbs unevenly. For a young man who also wants HCG, injection is the natural pick since the routine already involves needles.

### Can I train and gain muscle on TRT?

Yes, and it is one of the secondary benefits of TRT in a hypogonadal man: strength comes back, motivation in the gym returns, recovery improves, and modest but real lean-mass gains follow. That said, TRT at physiological doses (100 to 200 mg/week) is not a cycle: the gains look like what you could earn naturally, not the transformations of a supraphysiological run. For the boundary between the two, see [TRT vs steroid cycle](/en/guides/trt-vs-steroid-cycle).

### Is TRT really for life?

For most patients, yes. TRT durably suppresses LH and FSH; without an active restart protocol, the HPTA does not come back on its own — and even with a restart, some patients never fully recover. For primary hypogonadism (testicular origin), there is no recovery possible. For recent secondary hypogonadism in a young man, a supervised exit is sometimes feasible. The decision to start TRT should be made knowing it is most likely permanent — which is why the upfront diagnosis matters so much.